These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16824748)

  • 1. Mutational analysis of the hCDC4 gene in gastric carcinomas.
    Lee JW; Soung YH; Kim HJ; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
    Eur J Cancer; 2006 Sep; 42(14):2369-73. PubMed ID: 16824748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.
    Malyukova A; Dohda T; von der Lehr N; Akhoondi S; Corcoran M; Heyman M; Spruck C; Grandér D; Lendahl U; Sangfelt O
    Cancer Res; 2007 Jun; 67(12):5611-6. PubMed ID: 17575125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma.
    Cassia R; Moreno-Bueno G; Rodríguez-Perales S; Hardisson D; Cigudosa JC; Palacios J
    J Pathol; 2003 Dec; 201(4):589-95. PubMed ID: 14648662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hCDC4 gene mutations in endometrial cancer.
    Spruck CH; Strohmaier H; Sangfelt O; Müller HM; Hubalek M; Müller-Holzner E; Marth C; Widschwendter M; Reed SI
    Cancer Res; 2002 Aug; 62(16):4535-9. PubMed ID: 12183400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hCDC4 gene mutation is rare in colorectal carcinomas in Korean patients.
    Lee JW; Jeong EG; Lee SH; Yoo NJ; Lee SH
    Pathology; 2008 Apr; 40(3):305. PubMed ID: 18428053
    [No Abstract]   [Full Text] [Related]  

  • 6. hCDC4 variation in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Seto KK; Bell RS; Andrulis IL
    Cancer Genet Cytogenet; 2006 Sep; 169(2):138-42. PubMed ID: 16938571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutation of hCDC4 gene is rare in lung adenocarcinomas.
    Woo Lee J; Hwa Soung Y; Young Kim S; Woo Nam S; Sang Park W; Young Lee J; Jin Yoo N; Hyung Lee S
    Acta Oncol; 2006; 45(4):487-8. PubMed ID: 16760187
    [No Abstract]   [Full Text] [Related]  

  • 8. MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4.
    Li J; Guo Y; Liang X; Sun M; Wang G; De W; Wu W
    J Cancer Res Clin Oncol; 2012 May; 138(5):763-74. PubMed ID: 22270966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fbxw7/hCdc4 tumor suppressor in human cancer.
    Tan Y; Sangfelt O; Spruck C
    Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer.
    Kwak EL; Moberg KH; Wahrer DC; Quinn JE; Gilmore PM; Graham CA; Hariharan IK; Harkin DP; Haber DA; Bell DW
    Gynecol Oncol; 2005 Jul; 98(1):124-8. PubMed ID: 15913747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of hCDC4 can cause chromosomal instability.
    Rajagopalan H; Jallepalli PV; Rago C; Velculescu VE; Kinzler KW; Vogelstein B; Lengauer C
    Nature; 2004 Mar; 428(6978):77-81. PubMed ID: 14999283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer.
    Ekholm-Reed S; Spruck CH; Sangfelt O; van Drogen F; Mueller-Holzner E; Widschwendter M; Zetterberg A; Reed SI
    Cancer Res; 2004 Feb; 64(3):795-800. PubMed ID: 14871801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias.
    Song JH; Schnittke N; Zaat A; Walsh CS; Miller CW
    Leuk Res; 2008 Nov; 32(11):1751-5. PubMed ID: 18485478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low frequency of hCDC4 mutations in human primary ovarian cancer.
    Sgambato A; Cittadini A; Masciullo V; Di Salvatore M; Graziani C; Rettino A; Valdivieso P; Scambia G; Bianchino G; Zupa A; Improta G; Cifarelli RA
    Gynecol Oncol; 2007 May; 105(2):553-5. PubMed ID: 17320938
    [No Abstract]   [Full Text] [Related]  

  • 15. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
    Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
    Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer.
    Akhoondi S; Lindström L; Widschwendter M; Corcoran M; Bergh J; Spruck C; Grandér D; Sangfelt O
    Breast Cancer Res; 2010; 12(6):R105. PubMed ID: 21122106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes.
    Yu JC; Ding SL; Chang CH; Kuo SH; Chen ST; Hsu GC; Hsu HM; Hou MF; Jung LY; Cheng CW; Wu PE; Shen CY
    Carcinogenesis; 2009 Sep; 30(9):1562-70. PubMed ID: 19587092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability.
    Kemp Z; Rowan A; Chambers W; Wortham N; Halford S; Sieber O; Mortensen N; von Herbay A; Gunther T; Ilyas M; Tomlinson I
    Cancer Res; 2005 Dec; 65(24):11361-6. PubMed ID: 16357143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of the CASP6 gene in colorectal and gastric carcinomas.
    Lee JW; Kim MR; Soung YH; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
    APMIS; 2006 Sep; 114(9):646-50. PubMed ID: 16948818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frameshift mutations of ATBF1, WNT9A, CYLD and PARK2 in gastric and colorectal carcinomas with high microsatellite instability.
    An CH; Kim SS; Kang MR; Kim YR; Kim HS; Yoo NJ; Lee SH
    Pathology; 2010; 42(6):583-5. PubMed ID: 20854080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.